We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
SkinHealth Systems
SKIN
$87.6M
| $103K | ﹤0.01% |
+12,362
| New | +$128K |
|
|
ADAM
1652
Adamas Trust
ADAM
$803M
| $103K | ﹤0.01% |
+10,399
| New | +$103K |
|
1653
InflaRx
IFRX
$253M
| $102K | ﹤0.01% |
+22,900
| New | +$103K |
|
1654
EyePoint Inc
EYPT
$1.08B
| $102K | ﹤0.01% |
+11,700
| New | +$71.5K |
|
1655
IAMGOLD
IAG
$8.42B
| $101K | ﹤0.01% |
+38,557
| New | +$112K |
|
1656
Rush Street Interactive
RSI
$2.76B
| $99.8K | ﹤0.01% |
+32,000
| New | +$98.8K |
|
1657
Vodafone
VOD
$37.2B
| $98.2K | ﹤0.01% |
+10,392
| New | +$109K |
|
1658
Banco Bradesco
BBD
$37.9B
| $98.2K | ﹤0.01% |
+28,370
| New | +$87.6K |
|
|
FOCL
1659
EDAP TMS S.A.
FOCL
$230M
| $97.7K | ﹤0.01% |
+10,600
| New | +$108K |
|
|
MTA
1660
Metalla Royalty & Streaming
MTA
$712M
| $96.8K | ﹤0.01% |
22,300
+12,081
| +118% | +$57.7K |
|
|
FTCH
1661
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $94.3K | ﹤0.01% |
15,612
-378,610
| -96% | -$1.82M |
|
1662
Ardelyx
ARDX
$1.25B
| $94.1K | ﹤0.01% |
27,763
-979,126
| -97% | -$4.01M |
|
1663
Mistras Group
MG
$483M
| $93.4K | ﹤0.01% |
+12,100
| New | +$90K |
|
|
LOGC
1664
DELISTED
ContextLogic
LOGC
| $92.7K | ﹤0.01% |
+14,089
| New | +$112K |
|
|
ETWO
1665
DELISTED
E2open Parent Holdings
ETWO
| $91.5K | ﹤0.01% |
+16,331
| New | +$87.7K |
|
1666
EVgo
EVGO
$236M
| $91K | ﹤0.01% |
22,738
+9,238
| +68% | +$47.1K |
|
1667
Diamondrock Hospitality Co
DRH
$2.64B
| $90.8K | ﹤0.01% |
+11,336
| New | +$91.7K |
|
|
UNIT
1668
Uniti Group
UNIT
$2.26B
| $90.3K | ﹤0.01% |
+19,543
| New | +$73.5K |
|
1669
Tencent Music
TME
$15.5B
| $89.1K | ﹤0.01% |
+12,069
| New | +$91.2K |
|
1670
NatWest
NWG
$73.7B
| $88.8K | ﹤0.01% |
+14,502
| New | +$95.3K |
|
1671
Recursion Pharmaceuticals
RXRX
$1.61B
| $88.5K | ﹤0.01% |
11,849
-117,692
| -91% | -$823K |
|
1672
GeneDx Holdings
WGS
$2.05B
| $88.4K | ﹤0.01% |
+14,832
| New | +$117K |
|
1673
Unisys
UIS
$230M
| $88K | ﹤0.01% |
+22,100
| New | +$87.7K |
|
1674
Broadwind
BWEN
$91.3M
| $87.5K | ﹤0.01% |
22,900
+12,900
| +129% | +$53.9K |
|
|
HKD
1675
AMTD Digital
HKD
$500M
| $86.9K | ﹤0.01% |
+13,472
| New | +$90.6K |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.